ACTRN12620001169932尚未招募未知
Team Approach to Polypharmacy Evaluation and Reductionfor General Practice patients: the Australian TAPER (AusTAPER) study
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 360
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 70 Years 至 o limit（—）
- 性别
- All
入选标准
- •1.Person aged 70 years or older
- •2.Taking 5 or more medicines
- •3.Regular patient at the participating GP practice
- •4.Living in community
- •5.Patient willing to consider discontinuation of some medications
排除标准
- •1.Diagnosis of dementia (as recorded by the GP)
- •2.Inadequate language skills to participate
- •3.Place of residence is a Residential Aged Care Facility (RACF)
- •4.Are in terminal phase of life
- •5.Had a home medicines review by an accredited pharmacist (within the last 12 months)
研究者
相似试验
终止
不适用
AusTAPER Pilot: Team Approach to Polypharmacy Evaluation and Reduction A pilot study for older patients in General PracticePolypharmacyPublic Health - Health service researchACTRN12618000978268niversity of Newcastle24
尚未招募
4 期
The Australian Team Approach to Polypharmacy Evaluation and Reduction (AusTAPER) study for older hospital inpatientsPolypharmacyACTRN12618000979257niversity of Western Australia250
进行中（未招募）
不适用
AusTAPER Dem: Team Approach to Polypharmacy Evaluation and Reductionfor General Practice patients with dementia: the Australian TAPER Dem studydementiaACTRN12619000453189University of Western Australia31
终止
不适用
Team Approach to Polypharmacy Evaluation and Reduction in a Long-Term Care SettingLong-term CarePolypharmacyFrailtyNCT04055896McMaster University15
已完成
不适用
Team Approach to Polypharmacy Evaluation and ReductionMulti-morbidityMedication Therapy ManagementPolypharmacyNCT02942927McMaster University345